3,903 3,681 222 6.0% Sales and service income 3,628 3,588 40 1.1% Other income 127 92 35 38.0% Gain on disposal of investment 147 - 147 100% Cost of sales and services 3,400 3,351 49 1.5% SG&A expenses
17.58% 12.45 (317.64) 330.09 103.92% Non-operating income/expense Loss in impairment of assets (45.43) (124.62) 79.18 63.54% (Gain)/Loss from impairment of investment - (69.87) 69.87 100.00% (Gain)/Loss
, an increase of THB 32.79 million from 2017, as a result of the Company sold to two major customers. Other Income Other income of the Company and its subsidiaries consists of interest income, gain on
acquisition of Outrigger hotels and gain on exchange rate. Significant Events 1. Development of EYSE 43 - On August 22, 2018, the Company entered into JV Agreement in partnership collaboration with Daiwa House
(5.7%) 58(9.7%) (39.6%) Company 46.6(7.5%) 77(12.8%) (39.4%) TBSP 4.2(0.7%) (5)(0.9%) 178.4% Marvel Pack 0.1(0.01%) - 100.0% NP from operating 50.9(8.2%) 72(11.9%) (29.0%) One-time gain 0.9(0.1%) - 100.0
was no cost in Q3 2020. Gain on foreign currency exchange rate was at Baht 107.86 million in Q3 2021, compared to a gain of Baht 52.11 million in Q3 2020, caused by depreciation of Thai Baht. Gain on
น , partnership interests, business trust shares, ownership interests in business enterprises, ADRs (American Depositary Receipt) และ GDRs (Global Depositary Receipt) กองทุนเปิดไทยพาณิชย์ Genomic
, ownership interests in business enterprises, ADRs (American Depositary Receipt) และ GDRs (Global Depositary Receipt) กองทุนมี net exposure ในหน่วยลงทุนของกองทุนรวมต่างประเทศดังกล่าวโดยเฉลี่ยในรอบปีบัญชี ไม่
interests, business trust shares, ownership interests in business enterprises, ADRs (American Depositary Receipt) และ GDRs (Global Depositary Receipt) กองทุนมี net exposure ในหน่วยลงทุนของกองทุนรวมต่างประเทศ